(Q46416183)

3 March 2018

title

Antiadrenergic and hemodynamic effects of ranolazine in conscious dogs (English)

1 reference

3 March 2018

1 reference

Gong Zhao

1

1 reference

3 March 2018

Erin Walsh

2

1 reference

3 March 2018

John C Shryock

3

1 reference

3 March 2018

Eric Messina

4

1 reference

3 March 2018

Yuzhi Wu

5

1 reference

3 March 2018

Dewan Zeng

6

1 reference

3 March 2018

Xiaobin Xu

7

1 reference

3 March 2018

Manuel Ochoa

8

1 reference

3 March 2018

Stephen P Baker

9

1 reference

3 March 2018

Thomas H Hintze

10

1 reference

3 March 2018

Luiz Belardinelli

11

1 reference

3 March 2018

publication date

1 June 2011

1 reference

3 March 2018

Journal of Cardiovascular Pharmacology

published in

1 reference

3 March 2018

volume

57

1 reference

3 March 2018

issue

6

1 reference

3 March 2018

page(s)

639-647

1 reference

3 March 2018

Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndro

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5774223

Late sodium current inhibition as a new cardioprotective approach

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5774223

Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5774223

A mechanistic approach to assess the proarrhythmic risk of QT-prolonging drugs in preclinical pharmacologic studies

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5774223

Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5774223

Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5774223

Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5774223

Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5774223

Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5774223

Evidence that ranolazine behaves as a weak beta1- and beta2-adrenoceptor antagonist in the rat [correction of cat] cardiovascular system

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5774223

Modulation of alpha 1-adrenoceptors in rat left ventricle by ischaemia and acyl carnitines: protection by ranolazine

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5774223

Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less

3 November 2018

1 reference

12 December 2020

Norepinephrine-induced beta 1-adrenergic peripheral vasodilation in conscious dogs

1 reference

12 December 2020

Cardiovascular responses to the stimulation of alpha-1 and alpha-2 adrenoceptors in the conscious dog

1 reference

12 December 2020

A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents. Ranolazine Study Group

1 reference

12 December 2020

10.1097/FJC.0B013E31821458E8

Identifiers

DOI

1 reference

3 March 2018

PMC publication ID

5774223

1 reference

3 March 2018

PubMed publication ID

21633249

1 reference

3 March 2018